# Jeffrey S. Overcash, MD – FDA Inspection, Feb 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/jeffrey-s-overcash-md/db67b284-691b-4e7e-a6f1-caccd45c26c7
Source feed: FDA_Inspections

> FDA inspection 1008933 of Jeffrey S. Overcash, MD, February 03, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008933
- Company Name: Jeffrey S. Overcash, MD
- Inspection Date: 2017-02-03
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1223615 - 2023-11-17
- FDA Inspection 1072272 - 2018-11-09
- FDA Inspection 874640 - 2014-04-14

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/alexandra-b-pitkin/5e123821-0dd9-4a0d-ba57-f781008cda34)

Company: https://www.keypedia.com/companies/jeffrey-s-overcash-md/ac67a2af-442c-4f20-9b04-471344dadf99

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
